MARKET

SNSE

SNSE

Sensei Biotherapeutics, Inc.
NASDAQ
9.12
+0.68
+8.06%
After Hours: 8.90 -0.22 -2.41% 17:16 12/18 EST
OPEN
8.20
PREV CLOSE
8.44
HIGH
9.12
LOW
8.20
VOLUME
25.76K
TURNOVER
--
52 WEEK HIGH
18.35
52 WEEK LOW
5.00
MARKET CAP
11.50M
P/E (TTM)
-0.4760
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SNSE last week (1208-1212)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/11 12:05
Major Stakeholders Offload Shares in Sensei Biotherapeutics!
TipRanks · 12/11 02:07
Cambrian BioPharma Inc Reports Disposal of Sensei Biotherapeutics Common Shares
Reuters · 12/10 21:57
10% Owner James Peyer Reports Disposal of Sensei Biotherapeutics Inc. Common Shares
Reuters · 12/10 21:53
Major Stakeholders Offload Sensei Biotherapeutics Shares!
TipRanks · 12/09 02:03
Cambrian BioPharma Inc Disposes Common Shares of Sensei Biotherapeutics Inc
Reuters · 12/08 21:39
James Peyer, 10% Owner, Sells Common Shares of Sensei Biotherapeutics Inc
Reuters · 12/08 21:37
More
About SNSE
Sensei Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which is focused on the discovery and development of therapeutics for cancer patients. Through its Tumor Microenvironment Activated biologics (TMAb) platform, the Company develops conditionally active therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment to unleash T cells against tumors. Its lead investigational candidate is SNS-101, a conditionally active antibody designed to block the V-domain Ig suppressor of T cell activation checkpoint selectively within the low pH tumor microenvironment. It is also developing SNS-102, a conditionally active monoclonal antibody targeting V-Set and Immunoglobulin Domain Containing 4 (VSIG-4); SNS-103, a conditionally active monoclonal antibody targeting ecto-nucleoside triphosphate diphosphohydrolase-1 (ENTPDase1), CD39; and SNS-201, a conditionally active VISTAxCD28 bispecific antibody.

Webull offers Sensei Biotherapeutics Inc stock information, including NASDAQ: SNSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNSE stock methods without spending real money on the virtual paper trading platform.